BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 31628942)

  • 1. Recent Insights Into Mechanisms of β-Cell Lipo- and Glucolipotoxicity in Type 2 Diabetes.
    Lytrivi M; Castell AL; Poitout V; Cnop M
    J Mol Biol; 2020 Mar; 432(5):1514-1534. PubMed ID: 31628942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of lipotoxicity-induced pancreatic β-cell dysfunction.
    Benito-Vicente A; Jebari-Benslaiman S; Galicia-Garcia U; Larrea-Sebal A; Uribe KB; Martin C
    Int Rev Cell Mol Biol; 2021; 359():357-402. PubMed ID: 33832653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucolipotoxicity and beta cells in type 2 diabetes mellitus: target for durable therapy?
    van Raalte DH; Diamant M
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S37-46. PubMed ID: 21864750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Dynamic Effects of Isosteviol on Insulin Secretion and Its Inability to Counteract the Impaired β-Cell Function during Gluco-, Lipo-, and Aminoacidotoxicity: Studies In Vitro.
    Gu W; Rebsdorf A; Hermansen K; Gregersen S; Jeppesen PB
    Nutrients; 2018 Jan; 10(2):. PubMed ID: 29373526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of CD36 in Type 2 Diabetes Mellitus: β-Cell Dysfunction and Beyond.
    Moon JS; Karunakaran U; Suma E; Chung SM; Won KC
    Diabetes Metab J; 2020 Apr; 44(2):222-233. PubMed ID: 32347024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic signatures suggest o-phosphocholine to UDP-N-acetylglucosamine ratio as a potential biomarker for high-glucose and/or palmitate exposure in pancreatic β-cells.
    Yousf S; Sardesai DM; Mathew AB; Khandelwal R; Acharya JD; Sharma S; Chugh J
    Metabolomics; 2019 Mar; 15(4):55. PubMed ID: 30927092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GLP1-derived nonapeptide GLP1(28-36)amide protects pancreatic β-cells from glucolipotoxicity.
    Liu Z; Stanojevic V; Brindamour LJ; Habener JF
    J Endocrinol; 2012 May; 213(2):143-54. PubMed ID: 22414687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ER stress attenuation by Aloe-derived polysaccharides in the protection of pancreatic β-cells from free fatty acid-induced lipotoxicity.
    Kim K; Chung MH; Park S; Cha J; Baek JH; Lee SY; Choi SY
    Biochem Biophys Res Commun; 2018 Jun; 500(3):797-803. PubMed ID: 29684344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative and endoplasmic reticulum stress in β-cell dysfunction in diabetes.
    Hasnain SZ; Prins JB; McGuckin MA
    J Mol Endocrinol; 2016 Feb; 56(2):R33-54. PubMed ID: 26576641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucolipotoxicity: fuel excess and beta-cell dysfunction.
    Poitout V; Robertson RP
    Endocr Rev; 2008 May; 29(3):351-66. PubMed ID: 18048763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic steatosis in humans: cause or marker of lipotoxicity?
    van Raalte DH; van der Zijl NJ; Diamant M
    Curr Opin Clin Nutr Metab Care; 2010 Jul; 13(4):478-85. PubMed ID: 20489606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between GPR40 and lipotoxicity of the pancreatic β-cells as well as the effect of pioglitazone.
    Wu P; Yang L; Shen X
    Biochem Biophys Res Commun; 2010 Dec; 403(1):36-9. PubMed ID: 21036144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucolipotoxicity, β-Cells, and Diabetes: The Emperor Has No Clothes.
    Weir GC
    Diabetes; 2020 Mar; 69(3):273-278. PubMed ID: 31519699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipotoxicity in human pancreatic islets and the protective effect of metformin.
    Lupi R; Del Guerra S; Fierabracci V; Marselli L; Novelli M; Patanè G; Boggi U; Mosca F; Piro S; Del Prato S; Marchetti P
    Diabetes; 2002 Feb; 51 Suppl 1():S134-7. PubMed ID: 11815472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Denosumab Attenuates Glucolipotoxicity-Induced β-Cell Dysfunction and Apoptosis by Attenuating RANK/RANKL Signals.
    Lin SC; Tsou SH; Kuo CY; Chen WL; Wu KW; Lin CL; Huang CN
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polydatin prevents lipotoxicity-induced dysfunction in pancreatic β-cells by inhibiting endoplasmic reticulum stress and excessive autophagy.
    Jin W; Fan M; Zhang Y; Zhang Q; Jing C; Jiang R; Piao C; Sun L
    Phytomedicine; 2022 Nov; 106():154410. PubMed ID: 36030747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucolipotoxicity of the pancreatic beta-cell: myth or reality?
    Poitout V
    Biochem Soc Trans; 2008 Oct; 36(Pt 5):901-4. PubMed ID: 18793158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liraglutide protects against glucolipotoxicity-induced RIN-m5F β-cell apoptosis through restoration of PDX1 expression.
    Kornelius E; Li HH; Peng CH; Yang YS; Chen WJ; Chang YZ; Bai YC; Liu S; Huang CN; Lin CL
    J Cell Mol Med; 2019 Jan; 23(1):619-629. PubMed ID: 30353648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NR3C1/Glucocorticoid receptor activation promotes pancreatic β-cell autophagy overload in response to glucolipotoxicity.
    Wu T; Shao Y; Li X; Wu T; Yu L; Liang J; Zhang Y; Wang J; Sun T; Zhu Y; Chang X; Wang S; Chen F; Han X
    Autophagy; 2023 Sep; 19(9):2538-2557. PubMed ID: 37039556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guards and culprits in the endoplasmic reticulum: glucolipotoxicity and β-cell failure in type II diabetes.
    Karunakaran U; Kim HJ; Kim JY; Lee IK
    Exp Diabetes Res; 2012; 2012():639762. PubMed ID: 21977023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.